Anticoagulation with new antithrombotic agents - recommendations for daily practice

Abstract

The internists can indicate the new oral anticoagulants (rivaroxaban, apixaban and dabigatran) in the treatment of their patients now. We present an overview of their effects and several advice for possible monitoring in practice.

Keywords

• monitoring
• rivaroxaban
• apixaban
• dabigatran